Preliminary evaluation of [1-11C]octanoate as a PET tracer for studying cerebral ischemia: A PET study in rat and canine models of focal cerebral ischemia

Annals of Nuclear Medicine

Volumn 14, Issue 1, 2000, Pages 69-74

  Kuge, Yuji ^a,d   Kawashima, Hidefumi ^a   Hashimoto, Tadatoshi ^b   Imanishi, Mitsuaki ^b   Shiomi, Mie ^b   Minematsu, Kazuo ^c   Hasegawa, Yasuhiro ^c   Yamaguchi, Takenori ^c   Miyake, Yoshihiro ^a   Hashimoto, Naoto ^a  

^a Hokkaido University   (Japan)

^b TAKEDA PHARMACEUTICAL COMPANY LIMITED   (Japan)

^c NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cerebral ischemia; Dog; Positron emission tomography; Rat; I 11C octanoate

Indexed keywords

OCTANOIC ACID C 11; OCTANOIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN BLOOD FLOW; BRAIN ISCHEMIA; CONTROLLED STUDY; DOG; DRUG DISTRIBUTION; FATTY ACID METABOLISM; HEMISPHERE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOACTIVITY; RAT;

EID: 0034075556     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02990482     Document Type: Article

References (33)

1. Heiss W-D, Herholz K. Assessment of pathophysiology of stroke by positron emission tomography. Eur J Nucl Med 21:455-465, 1994.
2. 11C]-methyl, N-(methyl-1 propyl), (chloro-2 phenyl)-1 isoquinoline carboxamide-3 (PK-11195): a new ligand for peripheral benzodiazepine receptors. J Label Compds Radiopharm 21: 985-991, 1984.
3. 18F]PK-14105 as an alternative radioligand for peripheral type benzodiazepine binding sites, Int J Rad Appl Instrum [A] 41: 477-482, 1990.
4. Junck L, Jewwett DM, Kilbourn MR, Young AB, Kuhl DE. PET imaging of cerebral infarcts using a ligand for the peripheral benzodiazepine binding site. Neurology 40 (suppl. 1): 265, 1990.
5. Ramsay SC, Weiller C, Myers R, Cremer JE, Luthra SK, Lammertsma AA, et al. Monitoring by PET of macrophage accumulation in brain after ischemic stroke. Lancet 339: 1054-1055, 1992.
6. Oldendorf WH. Carrier-mediated blood-brain barrier transport of short-chain monocarboxylic organic acids. Am J Physiol 224: 1450-1453, 1973.
7. 4C]Octanoate: a fast functional marker of brain activity. Brain Res 335: 326-329, 1985.
8. Spector R. Fatty acid transport through the blood-brain barrier. J Neurochem 50: 639-643, 1988.
9. Cremer JE, Teal HM, Heath DF, Cavanagh JB. The influence of portocaval anastomosis on the metabolism of labeled octanoate, butyrate and leucine in rat brain. J Neurochem 28: 215-222, 1977.
10. Auestad N, Korsak RA, Morrow JW, Edmond J. Fatty acid oxidation and ketogenesis by astrocytes in primary culture. J Neurochem 56: 1376-1386, 1991.
11. Edmond J, Robbins RA, Bergstrom JD, Cole RA, de Vellis J. Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes and oligodendrocytes from developing brain in primary culture. J Neurosci Res 18: 551-561, 1987.
12. Edmond J. Energy metabolism in developing brain cells. Can J Physiol Pharmacol 70: S118-S129, 1992.
13. Norenberg MD, Martinez-Hernandez A. Fine structural localization of glutamine synthetase in astrocytes of rat brain. Brain Res 161: 303-310, 1979.
14. 11C]octanoate in rats: pharmacokinetic basis for its application as a radiopharmaceutical for studying brain fatty acid metabolism. Ann Nucl Med 9: 137-142, 1995.
15. 11C]Octanoate as a potential PET tracer for studying glial functions: PET evaluation in rats and cats. Nucl Med Biol 23: 1009-1012, 1996.
16. 11C]octanoate as a PET tracer. Ann Nucl Med 10: 395-399, 1996.
17. 11C]hexanoate as a PET tracer of fatty acid metabolism. Ann Nucl Med 9: 51-57, 1995.
18. 11C]hexanoate in the mouse: the effect of hypoxia, starvation and substrate competition. Ann Nucl Med 10: 265-270, 1996.
19. 11C]labeled hexanoate in anesthetized cats by means of positron emission tomography. Ann Nucl Med 10: 361-366, 1996.
20. Fowler JS, Gallagher BM, MacGregor RR, Wolf AP. Carbon-11 labeled aliphatic amines in lung uptake and metabolism studies: potential for dynamic measurements in vivo. J Pharmacol Exp Ther 198: 133-145, 1976.
21. Wienhard K, Dahlbom M, Eriksson L, Michel C, Bruckbauer T, Pietrzyk U, et al. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 18: 110-118, 1994.
22. Kuge Y, Minematsu K, Yamaguchi T, Miyake Y. Nylon monofilament for intraluminal middle cerebral artery occlusion in rats. Stroke 26: 1655-1658, 1995.
23. Minematsu K, Li L, Fisher M, Sotak CH, Davis MA, Fiandaca MS. Diffusion-weighted magnetic resonance imaging: rapid and quantitative detection of focal brain ischemia. Neurology 42: 235-240, 1992.
24. De Ley G, Weyne J, Demeester G, Stryckmans K, Goethals P. Van de Velde E, et al. Experimental thromboembolic stroke studied by positron emission tomography: immediate versus delayed reperfusion by fibrinolysis. J Cereb Blood Flow Metab 8: 539-545, 1988.
25. 14C]antipyrine. Am J Physiol 234: H59-H66, 1978.
26. Litton J-E, Holte S, Eriksson L. Evaluation of the Karolinska new positron camera system; the Scanditronix PC-2048-15B. IEEE Trans Nucl Sci 37: 743-748, 1990.
27. Ingvar M, Eriksson L, Rogers GA, Stone-Elander S, Widen L. Rapid feasibility studies of tracer for positron emission tomography: high-resolution PET in small animals with kinetic analysis. J Cereb Blood Flow Metab 11: 926-931, 1991.
28. Brownell AL, Kano M, McKinstry RC, Moskowitz MA, Rosen BR, Brownell GL. PET and MR studies of experimental focal stroke. J Comput Assist Tomogr 15: 376-380, 1991.
29. Kuge Y, Minematsu K, Hasegawa Y, Yamaguchi T, Mori H. Matsuura H, et al. Positron emission tomography for quantitative determination of glucose metabolism in normal and ischemic brains in rats: an insoluble problem by the Harderian Glands. J Cereb Blood Flow Metab 17: 116-120, 1997.
30. 18F]-2-fluoro-2-deoxy-D-glucose. J Cereb Blood Flow Metab 17: 1261-1262, 1997.
31. 11C]octanoate as a new radiopharmaceutical for assessing liver function using positron emission tomography. Nucl Med Biol 25: 467-472, 1998.
32. 11C]-3-(R,S)-methyloctanoic acid as potential markers for PET studies of fatty acid metabolism. J Label Compds Radiopharm 39: 181-193, 1997.
33. 11C]octanoate analogs in rats and a cat. Nucl Med Biol 25: 543-548, 1998.